Advertisement
Organisation › Details
PolyPeptide (Group)
PolyPeptide Group AG with its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange. *
Start | 2023-05-09 existent | |
Industry | contract manufacturing (biologicals) | |
Person | Varray, Stéphane (PolyPeptide 202501– Chief Commercial Officer before Corden Pharma + Lonza) | |
Street | 24 Neuhofstr. | |
City | 6340 Baar ZG | |
Tel | +41-43-502-0580 | |
Address record changed: 2023-05-11 | ||
Basic data | Employees | F: 1,001 to 5,000 (2023-05-10) |
Currency | CHF | |
Annual sales | 9,960,000 (income, total, consolidated (2022) 2022-12-31) | |
Profit | -1,163,631,000 (2022-12-31) | |
Cash | 10,061,000 (2022-12-31) | |
* Document for »About Section«: Numaferm GmbH. (5/9/23). "Press Release: PolyPeptide and Numaferm Announce Partnership to Leverage Their Expertise for the More Sustainable Production of Peptide-based APIs". Baar & Düsseldorf. | ||
Record changed: 2024-08-08 |
Advertisement
More documents for PolyPeptide (Group)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top